Moderna's RSV Vaccine May Lose Efficacy Faster Than GSK and Pfizer's
Moderna shares were falling after the biotech revealed data that might hurt its vaccine’s competitive position.
Source: marketwatch.com
Stay updated with breaking news from Michael Yee. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Moderna shares were falling after the biotech revealed data that might hurt its vaccine’s competitive position.
By Deena Beasley (Reuters) -Gilead Sciences on Tuesday said fourth-quarter revenue dipped 4% on lower sales of HIV drugs and its infused COVID-19 treatment ...
GILD earnings call for the period ending December 31, 2023.
Amgen Inc. beats earnings expectations. Reported EPS is $4.71, expectations were $4.66.